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Abstract 
Background: Complete or partial trisomy 10q involves a duplication of 10q, or the long arm of chromosome 10. Dis‑
tal 10q trisomy is a well‑recognized and defined but rare genetic syndrome in which duplication of distal segments of 
10q results in a pattern of malformations. Although abnormal chromosome phenotypes are commonly detected by 
visualization of chromosomes by traditional cytogenetic techniques, this approach is marginal in both diagnostic sen‑
sitivity and potential for biological interpretation, thus making implementation of advanced techniques and analysis 
methods an important consideration in a health service.
Case presentation: The present study describes the case of a Taiwanese boy from healthy parents with mental, 
growth, and psychomotor retardations. Additional clinical features included facial dysmorphism, microcephaly, brain 
atrophy, camptodactyly, and—as the first reported case—bilateral renal atrophy with chronic kidney disease stage 2 
and the presence of a renal cyst in one kidney. A novel 21.8 Mb copy number variation region in chromosome region 
10q23.1–10q25.1 was verified by array‑comparative genomic hybridization in combination with quantitative real‑time 
polymerase chain reaction. Subsequently, 200 protein‑coding genes were identified in this copy number variation 
region and analyzed for their biological meaning using the database for annotation, visualization and integrated 
discovery.
Conclusion: According to the result of gene functional enrichment analysis using database for annotation, visuali‑
zation and integrated discovery, the Wnt signaling pathway is the most pertinent to the gene content in the copy 
number variation region. A change in the expression levels of some Wnt signaling pathway components and of NFKB2 
and PTEN genes due to a gain in their gene copy number may be associated with the patient’s clinical outcomes 
including brain atrophy, bilateral renal atrophy with chronic kidney disease stage 2, a renal cyst in one kidney, and 
growth retardation.
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Background
Partial trisomy of the long (q) arm of chromosome 10 was 
first reported in 1965 [1], and since then over 30 reports 
published have described this genetic disorder that 
appeared in children. The distal 10q trisomy syndrome, 
which is well recognized and defined to distinguish it 
from other forms of partial trisomy, is a very rare chro-
mosomal disorder with the distal portion of the q arm of 
chromosome 10 appearing three times (trisomy) rather 
than twice in normal cells of the body. Typical features 
of this disorder consist of prenatal and postnatal growth 
retardation, hypotonia, mild to severe mental retarda-
tion, and mild to severe psychomotor retardation [2]. 
Affected individuals may have a distinctive dysmorphic 
appearance of the head and facial area; abnormalities 
of the hands and/or feet; and/or skeletal, cardiac, renal, 
and/or pulmonary defects [2]. The range and severity of 
symptoms vary from case to case, depending upon the 
span and location of the duplicated portion of chromo-
some 10q.
The diagnosis, treatment, and overall management of 
patients with 10q trisomy will substantially benefit from 
the identification of the patients’ novel chromosomal 
disorders and of molecular players involved in the clini-
cal abnormalities, since secondary genetic alterations 
are usually correlated with patients’ outcomes. In this 
case study, we first performed chromosome analysis of 
peripheral blood lymphocytes from the patient. As gen-
erally perceived, the traditional cytogenetic method is 
limited to obtaining results of gross structural abnor-
malities, and the method revealed no detectable abnor-
mal karyotype in this case. Afterward, we investigated 
the use of DNA copy number analysis as a tool to iden-
tify chromosomal breakpoints important to the biology 
of the patient’s clinical outcomes. Because microarray-
based comparative genomic hybridization (array-CGH) 
has been described as a robust and cost-effective alterna-
tive to traditional cytogenetic methodology in a previous 
paper [3], we performed whole-genome array-CGH in an 
attempt to detect genome-wide copy number variations 
(CNVs) in the patient’s blood DNA sample, followed by 
validation by quantitative real-time polymerase chain 
reaction (qPCR). We also performed a systematic inte-
grative analysis of the protein-coding genes identified 
within the copy number variation region (CNVR) using 
the database for annotation, visualization and integrated 
discovery (DAVID) in order to extract the genes’ biologi-
cal features or meaning, which might be associated with 
the patient’s clinical features.
Case presentation
The Taiwanese patient was the only child of healthy, non-
consanguineous parents, born at term after an uneventful 
pregnancy. His birth measurements were low for ges-
tational age: weight, 2,025  g (<3rd percentile); height, 
45.6  cm (<3rd percentile); and head circumference, 
31 cm (3rd percentile). Apgar scores were 9 at 1 min and 
10 at 5 min. There were no repeated miscarriages, men-
tal retardation, or malformation syndromes in the family 
history. He was referred for endocrinological evaluation 
at 4 years and 10 months of age due to short stature and 
underweight; his height was 99.7  cm (3rd percentile), 
weight was 12.8 kg (<3rd percentile), and head circumfer-
ence was 43  cm (<3rd percentile). Physical examination 
revealed dysmorphic features including microcephalus, a 
high forehead, drooping eyelids, short palpebral fissures, 
a bow-shaped mouth, malformed, posteriorly rotated 
ears, and camptodactyly. He also had left-sided inguinal 
hernia and received herniorrhaphy. Delayed psychomo-
tor development milestones were noted. Hearing test 
results were normal. His bone age was 4½  years. The 
results of a hormone survey, including thyroid function 
and insulin-like growth factor 1 tests and tandem mass 
spectrometry (MS/MS) evaluation, were normal. Echo-
cardiographic findings were nonspecific, and ultrasound 
examination showed that the size of the kidneys was 
small for his age (Figure  1a, b). A magnetic resonance 
imaging (MRI) scan of the brain revealed brain atro-
phy (Figure  1c, d). Chromosome analysis of peripheral 
blood lymphocytes showed a normal male karyotype. At 
the age of 9 years and 4 months, the patient received his 
individual intelligence test (WISC-IV), which revealed 
moderate mental retardation with a full scale score of 49. 
Repeated renal ultrasound examination showed bilateral 
renal atrophy with chronic kidney disease stage 2 (SCr: 
0.56 mg/dL; 24 h CCr: 84.8 mL/min/1.73 m2), and a sim-
ple renal cyst (1.13 ×  0.78  cm) was incidentally identi-
fied in the left kidney (Figure 1b). Other internal organs 
were normal. Subsequently, a molecular examination 
by array-CGH was performed to identify genetic break-
points important to the biology of the patient’s clinical 
outcomes.
Methods for array‑comparative genomic hybridization 
analysis
DNA extraction and array
Genomic DNA was extracted from the peripheral blood 
of the patient and of a healthy male control. After spec-
trometric measurement of DNA concentration, the DNA 
samples were stored at −20°C until used. Array-CGH 
was performed by Sofiva Genomics Laboratory (Taipei, 
Taiwan) using the CytoChip Oligo array (BlueGnome, 
Cambridge, UK) according to the suggestions from the 
International Standard Cytogenomic Array Consortium 
(ISCA). The array contained more than 60,000 oligonu-
cleotide probes, which covered the 22 autosomes and 2 
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sex chromosomes with an average probe spatial resolu-
tion of approximately 60  kb and comprised coding and 
non-coding human genome sequences sourced from the 
UCSC hg19 human genome (GRCh37, Genome Refer-
ence Consortium Human Reference 37, February 2009).
Array‑comparative genomic hybridization, microarray 
image, and data analysis
Digestion, labeling, hybridization, and data analy-
sis of genomic DNA were performed according to the 
CytoChip Oligo Reference Manual (http://www.cytochip.
com). In brief, sample and reference DNAs, 20 μg each, 
were fragmented, and 1.0–1.5  μg of the fragmented 
DNA was labeled using the Fluorescent Labeling Sys-
tem (dUTP) (BlueGnome). Labeled samples were puri-
fied, combined, and hybridized for 40 h at 65°C, 20 rpm, 
to the CytoChip Oligo slide (BlueGnome) against gen-
der-matched reference DNAs. Then the arrays were 
washed and scanned using a High-Resolution Microarray 
Scanner (Agilent Technologies, Santa Clara, CA, USA). 
Array images were analyzed and data were extracted with 
Agilent’s Feature Extraction Software, which uses a Lin-
ear Lowess algorithm to obtain background-subtracted 
and normalized intensity values.
Method for quantitative real‑time polymerase chain 
reaction analysis
A total of 34 representative target sequences (RTSs) 
were selected for validation of the CNVR determined 
by the array-CGH analysis and of the regions 62  kb 
upstream and downstream of the CNVR. For each 
RTS, a pair of primers (Additional file 1: Table S1) was 
designed using the Primer 3 web tool (http://bioinfo.
ut.ee/primer3-0.4.0/). In addition, the in silico polymer-
ase chain reaction (PCR) program from the University of 
California Santa Cruz (UCSC) browser (http://genome.
ucsc.edu) was used for specificity analysis to certify that 
the primer pair matched only the sequence of interest. 
Figure 1 Ultrasonographic and magnetic resonance imaging examinations at 9 years and 4 months of age. Renal ultrasound showed the small 
size of the kidneys for the patient’s age: a the right kidney (length, 70.2 mm) and b the left kidney (length, 75.9 mm) with a simple renal cyst 
(1.13 × 0.78 cm) indicated by an arrowhead. Magnetic resonance imaging revealed brain atrophy; c diffuse enlargement of the subarachnoid 
spaces, bilateral widening of the sylvian fissures, and hypomyelination of the anterior white matter; and d thinning of the corpus callosum.
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The actin gene was co-amplified with the RTSs and 
served as an endogenous Ref. [4]. The relative compara-
tive threshold cycle (2−Ct) method was used to quan-
tify copy number changes, where ΔΔCt =  (Ct RTS −  Ct 
Actin) Patient  −  (Ct RTS  −  Ct Actin) Healthy control [4, 5]. All 
qPCR reactions were run in triplicate using the ABI 7500 
Real-Time PCR System (Applied Biosystems, Foster City, 
CA, USA). PCR amplifications were performed in a total 
volume of 20  μL consisting of 1  μL of genomic DNA 
(approximately 50 ng), 1 μL (20 pM/μL) each of forward 
and reverse primers, 10 μL of Master Mix (2×), and 
water (Roche Applied Science, Indianapolis, IN, USA) 
under conditions of 95°C for 5 min followed by 40 cycles 
of 95°C for 10 s and 60°C for 10 s. The average Ct value 
was calculated from three replications of each sample 
and normalized against the endogenous reference gene 
(ACTB) to give the ΔCt value, from which 2−Ct was 
then calculated for each RTS. For autosomal chromo-
somes, a 2−Ct value around 1 indicated a normal copy 
number status for the RTS (without CNV), and a value 
around 1.5 indicated a triplicate CNV status.
Method for gene content and functional annotation
The gene content within the CNVR was retrieved from 
the UCSC Genome Database (GRCh37, https://genome.
ucsc.edu/) and the Ensembl genome browser 75 database 
(http://asia.ensembl.org/Homo_sapiens/Info/Index). The 
gene symbols retrieved were submitted to the DAVID 
resource [6] (http://david.abcc.ncifcrf.gov/summary.
jsp), where Gene Ontology (GO) analysis [7] and Kyoto 
Encyclopedia of Genes and Genomes (KEGG) pathway 
analysis [8] were performed to determine functional 
enrichment for protein-coding genes within the CNVR.
Results
Array‑comparative genomic hybridization and validation 
by quantitative real‑time polymerase chain reaction
In view of the clinical suspicion of the distal 10q trisomy 
syndrome, we performed genomic array-CGH analy-
sis on the patient’s blood DNA sample referenced to 
a normal male control DNA sample. The result of our 
array-CGH analysis was arr 10q23.1q25.1 (86,633,896–
108,397,379) × 3, (XY) × 1 (the International System for 
Human Cytogenetic Nomenclature, ISCN 2013), indi-
cating that the patient had a 21.76  Mb CNVR appear-
ing three times (trisomy) in the 10q23.1–10q25.1 region 
(Figure 2a). To address the limitation that the CytoChip 
Oligo array cannot detect DNA copy number changes in 
genomic regions that are not represented on the microar-
ray, we complemented the array-CGH result with qPCR 
analysis, performing validation of the CNVR along with 
its 62  kb upstream and downstream regions. For this 
validation, 34 selected RTSs were tested for their CNV 
status relative to the normal reference genomic DNA. 
Of the 34 RTSs, 23 consecutive RTSs representing the 
Ch10:86591156-108394653 (21.8  Mb) region were con-
firmed in their triplicate copy number status (Additional 
file 1: Table S1; Figure 2b). These results support the con-
clusion that a 21.8 Mb duplication was present in chro-
mosome region 10q23.1–10q25.1 of the patient.
Gene content of copy number variation region
For the chromosomal region encompassed by the CNVR, 
a total of 200 protein-coding genes, 25 pseudogenes, 10 
microRNAs, 3 processed transcripts, 2 antisense RNAs, 
1 miscellaneous RNA, 1 small nucleolar RNA, and 1 
small nuclear RNA were retrieved from the UCSC and 
Ensembl genome databases (Additional file 1: Table S2). 
GO analysis for the 200 protein-coding genes showed a 
predominant representation of genes categorized by bio-
logical process (BP) under the terms of the Wnt signaling 
pathway, oxidation–reduction, and spleen development 
(Figure 3, Additional file 1: Table S3), genes categorized 
by cellular compartment (CC) under the term of centro-
some (Additional file 1: Table S4), and genes categorized 
by molecular function (MF) under the terms of iron ion 
binding, oxygen binding, heme binding, and retinoid 
binding (Additional file 1: Table S5). KEGG pathway 
analysis revealed that these genes were by and large rep-
resented in metabolism-related pathways and the Wnt 
signaling pathway (Additional file 1: Table S6).
Discussion and conclusions
In this report, our patient’s clinical presentation (Table 1) 
raised suspicion of the distal 10q trisomy syndrome, 
which prompted conventional cytogenetic testing, also 
known as karyotyping. However, this method revealed 
no detectable abnormal karyotype in this case. Conven-
tional cytogenetic testing is known to have limitations 
due to poor chromosome morphology, inadequate meta-
phase yield, poor banding quality, and uniparental diso-
mies [9–11], which may account for missed detection by 
this method in the present case. Therefore, array-CGH, a 
recommended first-line test in most cytogenetic depart-
ments [12, 13], was used to help delineate the chromo-
somal abnormalities of our patient, and it demonstrated 
a 21.76  Mb CNVR in chromosome region 10q23.1–
10q25.1 (Figure 2a). Array-CGH has been shown to ena-
ble the genome-wide analysis of DNA copy numbers and 
allow screening of gains and losses of genetic material 
across the genome while offering the advantages of high 
resolution and high throughput [14].
Despite the increased resolution and higher diag-
nostic yield associated with array-CGH, there may be a 
concern that this method alone is also likely to be insuf-
ficient for the exact mapping of a CNVR, as the set of 
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oligonucleotide probes on a given microarray does not 
provide complete coverage of each chromosome, and 
some CNVs could be missed as a result. We reasoned 
that incorporating the additional CNVs detected by a 
different approach such as qPCR would result in a more 
precise determination of the size of the CNVR. There-
fore, we performed qPCR analysis to complement the 
array-CGH result and were able to conclude the CNVR 
to be 21.8 Mb in size (Figure 2b). The above-mentioned 
limitation of array-CGH also explains the need to design 
the PCR primers for the 34 selected RTSs outside the 
boundaries of the microarray’s oligonucleotide probes 
in order to better confirm the CNVR. After compar-
ing the CNVR identified in this study with the findings 
in previously published reports of distal 10q trisomy, we 
believe that the 21.8 Mb CNVR in the 10q23.1–10q25.1 
chromosome region is a novel finding. Regarding the 
conceivable genetic mechanisms involved in the CNV of 
our patient, it is possible that one of the parents was a 
carrier of a balanced insertional translocation involving 
the CNVR, and the CNVR was subsequently transmitted 
to the offspring [15]. Ideally, a karyotype analysis of the 
parents should provide some genetic information. Unfor-
tunately, karyotyping of the parents was precluded by 
their unique family culture, thereby making it difficult to 
ascertain the genetic condition involved in our patient’s 
distal 10q duplication.
The current case underlines the possible connection 
between clinical disorders and an aberrant biological 
process. The CNVR identified in this study covered a 
total of 200 protein-coding genes (Additional file 1: Table 
S2). The functions of some of these genes are classically 
a

































































Figure 2 Array‑comparative genomic hybridization and validation by quantitative real‑time polymerase chain reaction analysis. a Array‑compara‑
tive genomic hybridization analysis of patient genomic DNA vs. normal male genomic DNA. The characteristic duplication in the 10q23.1–10q25.1 
region is clearly detectable in both the chromosomal segmentation analysis (upper panel) and the chromosome 10 profile (bottom panel). b The 
result of quantitative real‑time polymerase chain reaction validation indicates that 23 successive representative target sequences representing the 
DNA sequence of Ch10:86591156–108394653 were confirmed in the triplicate copy number variation status (relative copy number ≥1.5).
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annotated as the related genes of the Wnt signaling path-
way (Additional file 1: Table S7), an evolutionarily con-
served cellular signaling pathway that plays a crucial role 
in various biological processes such as organogenesis, 
tissue homeostasis, and pathogenesis of many human 
diseases [16]. Given the critical role the Wnt signaling 
pathway plays in early development, including a pre-
sumed role in brain [17] and kidney [18] development, 
deregulated Wnt signaling is expected to be involved in 
many kidney diseases, including renal cell carcinoma, 
Wilms’ tumor, renal fibrosis, cystic kidney disease, and 
acute renal failure [18–24]. Importantly, functional anal-
ysis of the genes within our patient’s CNVR using DAVID 
revealed the Wnt signaling pathway as the most relevant 
biological process (Additional file 1: Table S3). Hence, 
it is likely that an aberrant Wnt signaling pathway due 
to a copy number gain of related genes contributed to 
our patient’s significant clinical features including brain 
atrophy, stage II chronic kidney disease, and a cyst in an 
atrophic kidney (Figure 1). Additionally, it is tempting to 
speculate that the gain of an extra copy of the WNT8B 
and LZTS2 genes was a causal factor for brain and kidney 
atrophy, respectively, in our patient. This hypothesis is 
supported by recent studies showing that aberrant early 
activation of the Wnt signaling pathway due to WNT8B 
overexpression resulted in defective brain development 
[25], and that a reduced level of nuclear β-catenin from 
LZTS2 overexpression inhibited the transcriptional activ-
ity mediated by the Wnt/β-catenin signaling pathway 
and resulted in suppression of renal development [26]. 
Finally, it is interesting to speculate that the growth retar-
dation and chronic kidney disease observed in the pre-
sent case were related to the gain in copy number of the 
PTEN and NFKB2 genes, respectively. The main func-


















Figure 3 Gene Ontology analysis. A total of 200 protein‑coding genes within the copy number variation region were subjected to Gene Ontology 
analysis and categorized by biological process. The logarithm was taken of the functional enrichment p‑values by database for annotation, visualiza‑
tion and integrated discovery. A log (p‑value) value around three indicates that the biological process is pertinent to the gene list.
Table 1 The common features of the distal 10q trisomy 
syndrome
* Features present in the present report’s described case.
Facial Musculoskeletal Other
Minor facial  
dysmorphism*
Microcephaly* Growth retardation*
High/large forehead* Hypotonia Psychomotor retarda‑
tion*
Fine eyebrows* Joint laxity Mental retardation*
Antimongoloid slants* Camptodactyly* Cardiac abnormalities
Ocular hypertelorism Scoliosis Ocular abnormalities
Epicanthic folds Short neck Renal abnormalities*
Flat nasal bridge* Small bones and 
hands*
Brain abnormalities*
Short nose Pulmonary defects
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which promotes cell proliferation [28]; thus, the presence 
of extra PTEN gene product may inhibit body growth. 
NFKB2 gene duplication has been reported to correlate 
with fetal pyelectasis [29], which may result in nephro-
uropathies [30].
In conclusion, the findings presented in this report 
demonstrate the presence of a novel 21.8  Mb CNVR in 
the 10q23.1–10q25.1 chromosome region of a patient. 
This is also the first identification of the protein-coding 
genes within the CNVR and analysis of their biological 
meaning using DAVID. As suggested by the results of 
DAVID-based gene functional analyses, a gain in copy 
number of some Wnt signaling pathway–related genes 
most likely resulted in aberrant Wnt signaling activ-
ity and thereby contributed to our patient’s clinical out-
comes including brain atrophy, bilateral renal atrophy 
with chronic kidney disease stage 2, and a simple renal 
cyst in the left kidney. In addition, our report may con-
tribute to a better understanding of the genotype–pheno-
type correlation in the involvement of PTEN and NFKB2 
genes in growth retardation and chronic kidney disease. 
Thus, our findings have revealed the gene content in the 
duplicated region of 10q23.1–10q25 trisomy and may 
provide useful information for further investigation of 
associations between biological processes and important 
clinical features of distal 10q trisomy.
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